Work directly with Boyan Litchev, MD, founder of Axiavita and former Chief Medical Officer of a publicly traded biotech company, with more than 20 years of drug development experience.
Dr. Boyan Litchev leads each engagement and aligns scientific, nonclinical, CMC, clinical, regulatory, and safety teams around your next development milestone. He helps teams build the evidence needed to advance from pre-IND planning through first-in-human, Phase 2, and pivotal studies and to support regulatory submissions. Axiavita brings in specialists as needed, with a scope tied to your program’s priorities, timeline, and budget.
Axiavita works with biotech and pharmaceutical companies across the United States, the European Union, Asia, and Australia.